不仅可以在Science上发表你的研究，还能赢取高额奖金!可谓名利双收的大好事。我们热烈欢迎国内神经调控领域内的青年科学家积极投稿。小编个人也非常期待下一位获奖的是来自中国的科学家。

　　接下来让我们详细了解一下奖项吧。

　　关于科学·品驰奖

　　科学·品驰神经调控奖旨在奖励通过物理(电、磁、光)刺激神经系统中的靶点来调节神经活动，并对转化医学产生重大影响的创新研究。

　　该奖项成立于2016年，由《科学》和《科学·转化医学》共同管理，每年评选出根据过去三年的研究成果所述的1500字以内的优秀论文。

　　科学·品驰神经调控奖的冠军将获得2.5万美元奖励，并在《科学》杂志上发表其获奖论文。冠亚军的论文也都将在《科学》官网上进行在线发表。

　　通常，奖项的颁奖典礼在每年的9月份举行，奖项联合发起方——品驰公司将为大奖得主参加颁奖典礼的行程提供赞助。

　　奖项联合发起方: Science/AAAS

　　美国科学促进协会(AAAS)成立于1848年，是世界上最大的综合性科学学会，与262个专业学协会协作，为全球1000多万名会员提供服务。AAAS也是期刊《科学》、《科学·转化医学》、《科学·信号转导》、《科学·进步》、《科学·免疫学》以及《科学·机器人》的出版方。其中，由著名发明家托马斯·爱迪生投资创办的《科学》是全世界经同行评议的综合科学类期刊中发行量最大的一本期刊，读者总数超过40万。

　　非营利性的AAAS(网站： www.aaas.org)对所有人开放，通过向公众传播科学价值、帮助政府制定科技政策、推动科学教育、协助科研人员的职业发展等活动，履行其“促进科学，服务社会”的使命。公众可以免费阅读《科学》的每日在线新闻和社论，并且，任何具有广泛公共卫生意义的论文以及所有发表12个月后的研究文章都将提供免费阅读。《科学》杂志将进一步通过各种努力，为世界上最贫穷国家的科研工作者提供免费阅读。

　　奖项联合发起方：《科学·转化医学》

　　由美国科学促进会出版的《科学·转化医学》(Science Translational Medicine)，是发表科学、工程学和医学交叉领域的先进研究论文的在线周刊。《科学·转化医学》的目标是通过提供一个论坛，在医学相关的既定学科和新兴学科中交流最新的生物医学研究发现，以促进人类健康。

　　尽管50年来，我们对人类生物学的基本理解和强大的新技术的出现已经取得了进展，但将这一知识转化为有效的新疗法和健康措施的速度却很慢。《科学·转化医学》旨在发表鉴定并填补生物医学研究和医学应用交叉处的科学知识空白的文章，以加速将这些知识转化为预防、诊断和治疗人类疾病的新对策。

　　奖项联合发起方：品驰公司

　　北京品驰医疗设备有限公司(以下简称“品驰”)创立于2008年，总部位于北京市中关村科技园区昌平园。品驰是专业从事脑起搏器、迷走神经刺激器、脊髓刺激器、骶神经刺激器等系列化神经调控产品研发、生产和销售的高新技术企业，致力于为广大帕金森病、癫痫、疼痛、尿失禁等功能神经疾病患者提供先进的治疗手段。

　　品驰聚集了材料、机械、信息、精密加工、临床医学等各类专业人才，拥有一支在疗法研究、产品研发、质量控制、市场开拓和企业管理等方面专业的高水平人才队伍。品驰是“神经调控技术国家工程实验室”的组成单位，与清华大学、众多临床医院紧密合作，建立起“产学研医”协同创新模式。品驰创立以来，先后承担了多项国家重点研发计划、国家科技支撑计划、北京市重大科技专项计划等课题，取得了众多完全自主知识产权的研究成果，获得了系列脑起搏器和迷走神经刺激器产品注册证并上市销售，打破了美国公司在神经调控产品领域的垄断。

　　作为优秀的企业公民，品驰将秉承“爱人如己，启搏希望”的宗旨，以守护国民健康为己任，持续提供可信赖的高品质产品和服务，让科技真正服务民生。

　　更加推动神经调控领域高速发展，激励品驰公司砥砺奋进的是，由清华大学李路明团队研发，由品驰公司进行成果转化和产业化的脑起搏器项目，荣获2018年度国家科学技术进步奖一等奖。

　　☆投稿须知：

　　Rules of Eligibility

　　Entrants must be a Junior Investigator with an advanced degree received in the last 10 years and must be 45 years or younger as of January 1, 2019.

　　The entrant's essay must describe their research and its implications for neuromodulation.

　　The entrant must have performed or directed the work described in the essay.

　　The research must have been performed during the previous three years.

　　Employees of PINS, its subsidiaries,Science and AAAS, and their relatives are not eligible for the prize.

　　Procedures for Entry

　　The entrant must submit the following items:

　　A completed Entry Form.

　　An essay, written by the entrant, which describes his or her research and places it in perspective with respect to current research in the field of neuromodulation. The essay must not exceed 1,500 words in length. The applicant must have done or directed all of the work and it must have been performed in the past three years.

　　A one-page letter of recommendation from his or her postdoctoral adviser, supervisor, or other senior colleague who is familiar with the entrant's work.

　　A Curriculum Vitae that includes the following:

　　Full citations of papers that the entrant has published on the research described in the essay.

　　Academic and professional awards and honors that the entrant has received; and Relevant professional experience.

　　Copies of two of the entrant's papers that are most relevant to the essay.

　　The Entry Form and additional submission materials must be submitted electronically through our prize management system.

　　温馨提示

　　本年度奖项征稿截止日期：

　　2019年3月15日

　　奖项网站：

　　https://www.sciencemag.org/prizes/science-pins-prize-neuromodulation

　　科学·品驰奖历届获奖者简介：

　　2018 Grand Winner

　　头奖获得者

　　Nir Grossman received a B.Sc. in physics from the Israeli Institute of Technology (Technion), an M.Sc. in electromagnetic engineering from the Technical University of Hamburg-Harburg, and a Ph.D. in neuroscience from Imperial College London. He then completed a postdoc training at the Massachusetts Institute of Technology (MIT) and Harvard University. Grossman is now an assistant professor at Imperial College London and a fellow of the UK Dementia Research Institute. The long-term goal of his research is to develop neuromodulatory interventions for brain disorders by direct control of the aberrant neural activity.

　　2018 Runner-up

　　次奖获得者

　　Aryn Gittis received undergraduate degrees from Brandeis University and a Ph.D. from the University of California, San Diego. After completing her postdoctoral fellowship at the Gladstone Institute of Neurological Disease–University of California, San Franciso, Gittis started her lab in the Department of Biological Sciences at Carnegie Mellon University in 2012. Her research uses mouse models of Parkinson's disease combined with electrophysiology and optogenetics to understand the cellular basis of motor dysfunction and to develop novel strategies for intervention.

　　2017 Grand Winner

　　头奖获得者

　　The author of the prize-winning essay, Meaghan Creed, earned her H.B.Sc. and Ph.D. degrees from the University of Toronto and completed postdoctoral training at the University of Geneva. As an assistant professor at the University of Maryland School of Medicine, she is investigating the cellular and synaptic basis of bipolar and substance use disorders, with the goal of developing circuit-based interventions for these conditions.

　　2017 Runner-up

　　次奖获得者

　　Raag Airan, for his essay “Neuromodulation with nanoparticles.” Airan received his undergraduate degrees in mathematics and physics from the Massachusetts Institute of Technology and his M.D. and Ph.D. in Bioengineering from Stanford University. He then completed a clinical residency in radiology and a fellowship in neuroradiology at Johns Hopkins University.

　　历届颁奖现场盛况

2017年首届颁奖典礼颁奖嘉宾与获奖者合影，山东济南。

2017年首届颁奖典礼，Science学术编辑Priscilla Kelly(左一)，清华大学李路明教授(右一)与头奖次奖获得者。山东济南。

2018年第二届颁奖典礼，嘉宾与获奖者合影，北京。

　　为推动(青年)科学家的科研工作，促进学科发展，《科学》杂志/美国科学促进会目前设有5个奖项，奖励相关领域内的优秀科研成果，除本文的重点Science & PINS Prize for Neuromodulation(科学·品驰神经调控奖)外，另外4个奖项分别是：Eppendorf &Science Prize for Neurobiology, Sartorius & Science Prize for Regenerative Medicine & Cell Therapy, AAAS Newcomb Cleveland Prize, Science & SciLifeLab Prize for Young Scientists(清华大学博士后万蕊雪因其在剪接体三维结构及RNA剪接方面的研究成果，当选为2018年度细胞及分子生物学类别的获奖者。)